Wacker Chemie
Specialty Chemicals
Germany
EU Taxonomy summary
76.8% of Wacker Chemie's revenues are EU Taxonomy eligible, with 0.13% also being Taxonomy aligned. 53.8% of Wacker Chemie's capital expenditures are EU Taxonomy eligible, with 0.01% also being Taxonomy aligned. Additionally, 48% of Wacker Chemie's operating expenses are EU Taxonomy eligible, with 0.03% also being Taxonomy aligned.
Wacker Chemie's revenues breakdown
Wacker Chemie's capital expenditures breakdown
Wacker Chemie's operating expenses breakdown
EU Taxonomy full disclosure
Revenues
FY2024 | Code | Value (EURm) | Proportion of total | CCM | CCA | WTR | PPC | CE | BIO | CCM DNSH | CCA DNSH | WTR DNSH | PPC DNSH | CE DNSH | BIO DNSH | Minimum safeguards | Previous year proportion | Category enabling activity | Category transitional activity | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.17 = Manufacture of plastics in primary form |
CCM 3.17 | 7.5 | 0.13% | Y | N/EL | N/EL | N/EL | N/EL | N/EL | Y | Y | Y | Y | Y | Y | Y | 0.1% | T | ||
Turnover of environmentally sustainable activities (Taxonomy-aligned) (A.1) |
7.5 | 0.13% | 100% | 0% | 0% | 0% | 0% | 0% | Y | Y | Y | Y | Y | Y | Y | 0.1% | ||||
Of which enabling |
0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | ||||||||||||
Of which transitional |
7.5 | 0.13% | 100% | Y | Y | Y | Y | Y | Y | Y | 0.1% | T | ||||||||
3.17 = Manufacture of plastics in primary form |
CCM 3.17 | 4,242.1 | 74.1% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 66.9% | ||||||||||
1.1 = Manufacture of active pharmaceutical ingredients (API) or active substances |
PPC 1.1 | 144.4 | 2.5% | N/EL | N/EL | N/EL | EL | N/EL | N/EL | 1.65% | ||||||||||
Turnover of Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) (A.2) |
4,386.4 | 76.7% | 96.71% | 0% | 0% | 3.292% | 0% | 0% | 68.6% | |||||||||||
A. Turnover of Taxonomy eligible activities (A.1+A.2) |
4,393.9 | 76.8% | 68.7% | |||||||||||||||||
Turnover of Taxonomy-non-eligible activities |
1,327.8 | 23.2% | ||||||||||||||||||
Total (A+B) |
5,721.8 | 100% |
Show more...Show less...
Capital expenditures
FY2024 | Code | Value (EURm) | Proportion of total | CCM | CCA | WTR | PPC | CE | BIO | CCM DNSH | CCA DNSH | WTR DNSH | PPC DNSH | CE DNSH | BIO DNSH | Minimum safeguards | Previous year proportion | Category enabling activity | Category transitional activity | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.17 = Manufacture of plastics in primary form |
CCM 3.17 | 0.08 | 0.01% | Y | N/EL | N/EL | N/EL | N/EL | N/EL | Y | Y | Y | Y | Y | Y | Y | 0.02% | T | ||
CapEx of environmentally sustainable activities (Taxonomy-aligned) (A.1) |
0.08 | 0.01% | 100% | 0% | 0% | 0% | 0% | 0% | Y | Y | Y | Y | Y | Y | Y | 0.02% | ||||
Of which enabling |
0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | ||||||||||||
Of which transitional |
0.08 | 0.01% | 100% | Y | Y | Y | Y | Y | Y | Y | 0.02% | T | ||||||||
3.17 = Manufacture of plastics in primary form |
CCM 3.17 | 376.7 | 47.2% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 31% | ||||||||||
1.1 = Manufacture of active pharmaceutical ingredients (API) or active substances |
PPC 1.1 | 52.2 | 6.5% | N/EL | N/EL | N/EL | EL | N/EL | N/EL | 15.9% | ||||||||||
CapEx of Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) (A.2) |
428.6 | 53.8% | 87.891% | 0% | 0% | 12.179% | 0% | 0% | 46% | |||||||||||
A. CapEx of Taxonomy eligible activities (A.1+A.2) |
428.6 | 53.8% | 46.8% | |||||||||||||||||
CapEx of Taxonomy-non-eligible activities |
368.6 | 46.2% | ||||||||||||||||||
Total (A+B) |
797.5 | 100% |
Show more...Show less...
Operating expenses
FY2024 | Code | Value (EURm) | Proportion of total | CCM | CCA | WTR | PPC | CE | BIO | CCM DNSH | CCA DNSH | WTR DNSH | PPC DNSH | CE DNSH | BIO DNSH | Minimum safeguards | Previous year proportion | Category enabling activity | Category transitional activity | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.17 = Manufacture of plastics in primary form |
CCM 3.17 | 0.19 | 0.03% | Y | N/EL | N/EL | N/EL | N/EL | N/EL | Y | Y | Y | Y | Y | Y | Y | 0.02% | T | ||
OpEx of environmentally sustainable activities (Taxonomy-aligned) (A.1) |
0.19 | 0.03% | 100% | 0% | 0% | 0% | 0% | 0% | Y | Y | Y | Y | Y | Y | Y | 0.02% | ||||
Of which enabling |
0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | ||||||||||||
Of which transitional |
0.19 | 0.03% | 100% | Y | Y | Y | Y | Y | Y | Y | 0.02% | T | ||||||||
3.17 = Manufacture of plastics in primary form |
CCM 3.17 | 350.1 | 46.3% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 47.9% | ||||||||||
1.1 = Manufacture of active pharmaceutical ingredients (API) or active substances |
PPC 1.1 | 12.8 | 1.7% | N/EL | N/EL | N/EL | EL | N/EL | N/EL | 1.5% | ||||||||||
OpEx of Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) (A.2) |
362.8 | 48% | 96.499% | 0% | 0% | 3.528% | 0% | 0% | 49.4% | |||||||||||
A. OpEx of Taxonomy eligible activities (A.1+A.2) |
363 | 48% | 49.5% | |||||||||||||||||
OpEx of Taxonomy-non-eligible activities |
392.8 | 52% | ||||||||||||||||||
Total (A+B) |
755.8 | 100% |
Show more...Show less...